Shawn Tomasello
Chairman chez GAMIDA CELL LTD.
Fortune : 32 350 $ au 31/03/2024
Profil
Ms. Shawn C.
Tomasello is an Independent Director at Cabaletta Bio, Inc., an Independent Director at AlloVir, Inc., an Independent Director at 4D Molecular Therapeutics, Inc. and a Chairman at Gamida Cell Ltd.
She is on the Board of Directors at Cabaletta Bio, Inc., AlloVir, Inc., 4D Molecular Therapeutics, Inc., Centrexion Therapeutics Corp.
and Geneos Therapeutics, Inc. Ms. Tomasello was previously employed as an Independent Director by TCR2 Therapeutics, Inc., an Independent Director by Abeona Therapeutics, Inc., an Independent Non-Executive Director by Mesoblast Ltd., an Independent Director by UroGen Pharma Ltd., a Chief Commercial Officer by Kite Pharma, Inc., an Independent Director by Diplomat Pharmacy, Inc., a Chief Executive Officer by Shawn Tomasello Consulting LLC, a Chief Commercial Officer by Pharmacyclics LLC, a Senior VP, President-Hematology & Oncology by Celgene Corp., a National Director-Hematology by Genentech, Inc., a Trustee by BioNJ, Inc., and a Non-Executive Director by Oxford BioTherapeutics Ltd.
She also served on the board at Principia Biopharma, Inc. and Clementia Pharmaceuticals, Inc. She received her undergraduate degree from the University of Cincinnati (Ohio) and an MBA from Murray State University (Kentucky).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALLOVIR INC
0,03% | 11/05/2023 | 35 000 ( 0,03% ) | 26 425 $ | 31/03/2024 |
GAMIDA CELL LTD.
0,12% | 15/03/2024 | 164 577 ( 0,12% ) | 5 925 $ | 31/03/2024 |
| 23/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 | |
MESOBLAST LIMITED
-.--% | 31/08/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Shawn Tomasello
| Sociétés | Poste | Début |
|---|---|---|
| CENTREXION THERAPEUTICS CORPORATION | Director/Board Member | 26/06/2017 |
| GAMIDA CELL LTD. | Chairman | 20/03/2023 |
| 4D MOLECULAR THERAPEUTICS, INC. | Director/Board Member | 18/11/2020 |
| ALLOVIR, INC. | Director/Board Member | 29/03/2022 |
| CABALETTA BIO, INC. | Director/Board Member | 21/07/2023 |
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Director/Board Member | - |
Anciens postes connus de Shawn Tomasello
| Sociétés | Poste | Fin |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Director/Board Member | 01/06/2023 |
| MESOBLAST LIMITED | Director/Board Member | 17/08/2022 |
| UROGEN PHARMA LTD. | Director/Board Member | 08/06/2022 |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Shawn Tomasello
| Murray State University (Kentucky) | Masters Business Admin |
| University of Cincinnati (Ohio) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| MESOBLAST LIMITED | Health Technology |
| GAMIDA CELL LTD. | Health Technology |
| UROGEN PHARMA LTD. | Health Technology |
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| ALLOVIR, INC. | Health Technology |
| CABALETTA BIO, INC. | Health Technology |
| Entreprise privées | 13 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
Centrexion Therapeutics Corp.
 Centrexion Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Centrexion Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain. Its product pipeline includes CNTX-4975, CNTX-0290, CNTX-6970, CNTX-2022, CNTX-6016, and intrathecal platform. The company was founded by Sol J. Barer and Jeffrey B. Kindler in February 2013 and is headquartered in Boston, MA. | Health Technology |
Diplomat Pharmacy, Inc.
 Diplomat Pharmacy, Inc. Drugstore ChainsRetail Trade Diplomat Pharmacy, Inc. engages in the provision of specialty pharmacy and infusion services. It operates under the Specialty and Pharmacy Benefit Management (PBM) segments. The Specialty segment includes dispensing prescription drugs for home delivery at the time the drugs are physically delivered which is the point in time when control transfers to the customer. The PBM segment focuses on providing pharmacy benefit management services including mail order pharmacy and specialty pharmacy services. The company was founded by Dale Hagerman and Philip R. Hagerman in 1975 and is headquartered in Flint, MI. | Retail Trade |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Clementia Pharmaceuticals, Inc.
 Clementia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Clementia Pharmaceuticals, Inc. provides healthcare services. It is a biopharmaceutical company, which focuses on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease and involves in development and commercialization of treatments for people living with rare diseases. Clementia Pharmaceuticals was founded by Clarissa Desjardins and Jean-Claude Tardif on November 5, 2010 and is headquartered in Montreal, Canada. | Health Technology |
Shawn Tomasello Consulting LLC
 Shawn Tomasello Consulting LLC Miscellaneous Commercial ServicesCommercial Services Shawn Tomasello Consulting LLC provides business consulting services. The private company is based in Miramar Beach. The American company was founded by Shawn Cline Tomasello. | Commercial Services |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Health Technology |
